Structuring Optimal Health Through Targeted TherapiesTM

Meet Our Team

Chuck Hadley, J.D., M.B.A

Finance and Strategic Business Advisor

Richard L. Sherman, J.D.

Business Transaction Advisor

Robert Rausch, MBA

Business and Finance Advisor

Brian Druker, MD

Drug Development and Clinical Trial Advisor

Richard (Rick) C. Winneker, PhD

Drug Development Advisor

Briggs W. Morrison, M.D.

Drug Development and Clinical Trial Advisor

Rosemary Mazanet, MD, PhD

Drug Development and Clinical Trial Advisor

Scott A. Waldman, MD, PhD, FCP, FAHA

Clinical Trial Design Advisor

Bruno Calabretta, MD, PhD

​Scientific Advisor

Bruce H. Sokoloff MD FACP

Medical Advisor

Contact Us

Newsletter Sign up

Information

Therapy Architects designs and develops novel targeted cancer therapies for both children and adults. Every patient is unique and not all respond to available products. Our team is focused on improving outcomes by optimizing efficacy and reducing toxic side effects of chemotherapeutic agents where, the cure can sometimes be worse than the disease itself.